Analysts have advised investors to buy Ashok Leyland Ltd., BSE Ltd. and Alkem Laboratories Ltd. among other stocks on Thursday.
Aamar Deo Singh, senior vice president, research at Angel One Ltd., Nilesh Jain, head VP- technical and derivatives research, (equity research), Centrum Broking Ltd. and Chandan Taparia, head of technical and derivatives research, Motilal Oswal Financial Services Ltd. shared their insights with NDTV Profit.
Ashok Leyland
Singh recommends purchasing the stock at Rs 218, with a target of Rs 247 and a stop loss of Rs 197. Over the past year, the stock has risen 26.83%. Its relative strength index was at 56.
BSE
Jain recommends purchasing the stock at Rs 5,339, with a target of Rs 5,540 and a stop loss of Rs 5,225. Over the past year, the stock has risen 128.67%. Its relative strength index was at 47.
Bharti Airtel
Taparia recommends purchasing the stock at Rs 1,711, with a target of Rs 1,785 and a stop loss of Rs 1,675. Over the past year, the stock has risen 53.11%. Its relative strength index was at 65.
Alkem Laboratories
Singh recommends purchasing the stock at Rs 4,700, with a target of Rs 4,935 and a stop loss of Rs 4,547. Over the past year, the stock has fallen 11.05%. Its relative strength index was at 30.
SRF
Taparia recommends purchasing the stock at Rs 2,828, with a target of Rs 2,970 and a stop loss of Rs 2,750. Over the past year, the stock has risen 21.74%. Its relative strength index was at 62.
RECOMMENDED FOR YOU
Ashok Leyland Stock Q1 Review — Nirmal Bang Maintains 'Buy', Says Margins To Expand On Better Mix, Pricing
Aug 18, 2025
Ashok Leyland Q1 Results: Profit Up 13%, Margin Expands
Aug 14, 2025
Vodafone Idea, IOC, Ashok Leyland, Glenmark Pharma Q1 Results Today — Earnings Estimates
Aug 14, 2025
Ashok Leyland Q1 Results: Date, Share Price History, Earnings Call Schedule And More
Aug 13, 2025
POPULAR